Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Korro Bio, Inc.KRRO · Entity 6388 | Director | June 11, 2024 | June 12, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Korro Bio, Inc.
Report date June 11, 2024 · Filed June 12, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $42.19 · Expires 2034-06-10 | Direct | 5,190 |
Reported balance
After 2024-06-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-06-11 · Grant · Acquired 5,190 · Balance 5,190 F1: The shares subject to the option vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders, subject to continued service as a non-employee director through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders, subject to continued service as a non-employee director through the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2024 Filed Jun 12, 2024 21:15 UTC | Korro Bio, Inc. KRRO · Entity 6388 | GrantStock Option (Right to Buy) · Derivative | 5,190 | $0.00 Strike: $42.19 | $0.00 |
DisclosureSEC source: 0000950170-24-072551 · ownership.xml · derivative · entry 1 Lucchino David L. · CIK 0001785288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,190 Underlying: Common Stock · 5,190 shares Expires 2034-06-10 F1 · derivative.exercise_date: The shares subject to the option vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders, subject to continued service as a non-employee director through the applicable vesting date. Read SEC document |
| November 22, 2023 Filed Nov 28, 2023 01:48 UTC | Korro Bio, Inc. KRRO · Entity 6388 | SaleCommon Stock | 202 | $38.82 | $7,841.54 |
DisclosureSEC source: 0000950170-23-066217 · ownership.xml · nonDerivative · entry 4 Lucchino David L. · CIK 0001785288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,150 F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance restricted stock units, and does not represent a discretionary trade by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.62 to $39.015, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request. Read SEC document |
| November 22, 2023 Filed Nov 28, 2023 01:48 UTC | Korro Bio, Inc. KRRO · Entity 6388 | SaleCommon Stock | 614 | $37.98 | $23,322.42 |
DisclosureSEC source: 0000950170-23-066217 · ownership.xml · nonDerivative · entry 3 Lucchino David L. · CIK 0001785288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,352 F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance restricted stock units, and does not represent a discretionary trade by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.52 to $38.35, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request. Read SEC document |
| November 22, 2023 Filed Nov 28, 2023 01:48 UTC | Korro Bio, Inc. KRRO · Entity 6388 | SaleCommon Stock | 230 | $36.74 | $8,449.99 |
DisclosureSEC source: 0000950170-23-066217 · ownership.xml · nonDerivative · entry 2 Lucchino David L. · CIK 0001785288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,966 F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance restricted stock units, and does not represent a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.40 to $37.20, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request. Read SEC document |
| November 22, 2023 Filed Nov 28, 2023 01:48 UTC | Korro Bio, Inc. KRRO · Entity 6388 | SaleCommon Stock | 110 | $35.99 | $3,958.60 |
DisclosureSEC source: 0000950170-23-066217 · ownership.xml · nonDerivative · entry 1 Lucchino David L. · CIK 0001785288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,196 F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance restricted stock units, and does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.26 to $36.06, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request. Read SEC document |
| November 10, 2023 Filed Nov 22, 2023 21:05 UTC | Korro Bio, Inc. KRRO · Entity 6388 | SaleCommon Stock | 34 | $46.23 | $1,571.65 |
DisclosureSEC source: 0000950170-23-065866 · ownership.xml · nonDerivative · entry 9 Lucchino David L. · CIK 0001785288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,306 F4 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs, and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Total number of shares of common stock is adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023. Read SEC document |
| November 10, 2023 Filed Nov 22, 2023 21:05 UTC | Korro Bio, Inc. KRRO · Entity 6388 | SaleCommon Stock | 67 | $45.53 | $3,050.38 |
DisclosureSEC source: 0000950170-23-065866 · ownership.xml · nonDerivative · entry 8 Lucchino David L. · CIK 0001785288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,340 F4 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs, and does not represent a discretionary trade by the Reporting Person. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.07 to $46.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request. F2 · balance_after: Total number of shares of common stock is adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023. Read SEC document |
| November 10, 2023 Filed Nov 22, 2023 21:05 UTC | Korro Bio, Inc. KRRO · Entity 6388 | SaleCommon Stock | 191 | $44.01 | $8,406.56 |
DisclosureSEC source: 0000950170-23-065866 · ownership.xml · nonDerivative · entry 7 Lucchino David L. · CIK 0001785288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,407 F4 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs, and does not represent a discretionary trade by the Reporting Person. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.87 to $44.175, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request. F2 · balance_after: Total number of shares of common stock is adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023. Read SEC document |
| November 10, 2023 Filed Nov 22, 2023 21:05 UTC | Korro Bio, Inc. KRRO · Entity 6388 | SaleCommon Stock | 225 | $43.17 | $9,713.70 |
DisclosureSEC source: 0000950170-23-065866 · ownership.xml · nonDerivative · entry 6 Lucchino David L. · CIK 0001785288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,598 F4 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs, and does not represent a discretionary trade by the Reporting Person. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.75 to $43.625, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request. F2 · balance_after: Total number of shares of common stock is adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023. Read SEC document |
| November 10, 2023 Filed Nov 22, 2023 21:05 UTC | Korro Bio, Inc. KRRO · Entity 6388 | SaleCommon Stock | 41 | $41.94 | $1,719.65 |
DisclosureSEC source: 0000950170-23-065866 · ownership.xml · nonDerivative · entry 5 Lucchino David L. · CIK 0001785288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,823 F4 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs, and does not represent a discretionary trade by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.45 to $42.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request. F2 · balance_after: Total number of shares of common stock is adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023. Read SEC document |
| November 10, 2023 Filed Nov 22, 2023 21:05 UTC | Korro Bio, Inc. KRRO · Entity 6388 | SaleCommon Stock | 373 | $39.59 | $14,766.66 |
DisclosureSEC source: 0000950170-23-065866 · ownership.xml · nonDerivative · entry 4 Lucchino David L. · CIK 0001785288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,864 F4 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs, and does not represent a discretionary trade by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.155 to $40.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request. F2 · balance_after: Total number of shares of common stock is adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023. Read SEC document |
| November 10, 2023 Filed Nov 22, 2023 21:05 UTC | Korro Bio, Inc. KRRO · Entity 6388 | SaleCommon Stock | 37 | $37.92 | $1,403.20 |
DisclosureSEC source: 0000950170-23-065866 · ownership.xml · nonDerivative · entry 3 Lucchino David L. · CIK 0001785288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,237 F4 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs, and does not represent a discretionary trade by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.575 to $37.955, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request. F2 · balance_after: Total number of shares of common stock is adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023. Read SEC document |
| November 03, 2023 Filed Nov 22, 2023 21:05 UTC | Korro Bio, Inc. KRRO · Entity 6388 | Exercise / conversionRestricted Stock Units · Derivative | 5,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-065866 · ownership.xml · derivative · entry 10 Lucchino David L. · CIK 0001785288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects shares of the Issuer's common stock received upon vesting of restricted stock units ("RSUs") granted January 26, 2023 as adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023. F1 · shares: Reflects shares of the Issuer's common stock received upon vesting of restricted stock units ("RSUs") granted January 26, 2023 as adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023. F1 · derivative.exercise_date: Reflects shares of the Issuer's common stock received upon vesting of restricted stock units ("RSUs") granted January 26, 2023 as adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023. F1 · derivative.expiration_date: Reflects shares of the Issuer's common stock received upon vesting of restricted stock units ("RSUs") granted January 26, 2023 as adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023. F1 · derivative.underlying_shares: Reflects shares of the Issuer's common stock received upon vesting of restricted stock units ("RSUs") granted January 26, 2023 as adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023. Read SEC document |
| November 03, 2023 Filed Nov 22, 2023 21:05 UTC | Korro Bio, Inc. KRRO · Entity 6388 | GrantCommon Stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-065866 · ownership.xml · nonDerivative · entry 2 Lucchino David L. · CIK 0001785288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,274 F3 · price: Reflects shares of the Issuer's common stock received upon execution of a separation agreement effective November 3, 2023 resulting in vesting of performance RSUs granted April 11, 2022, as adjusted for the 1-for-50 reverse stock split effected by the Issuer on November 3, 2023. F2 · balance_after: Total number of shares of common stock is adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023. Read SEC document |
| November 03, 2023 Filed Nov 22, 2023 21:05 UTC | Korro Bio, Inc. KRRO · Entity 6388 | Exercise / conversionCommon Stock | 5,600 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-065866 · ownership.xml · nonDerivative · entry 1 Lucchino David L. · CIK 0001785288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,274 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects shares of the Issuer's common stock received upon vesting of restricted stock units ("RSUs") granted January 26, 2023 as adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023. F2 · balance_after: Total number of shares of common stock is adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023. Read SEC document |
| August 21, 2023 Filed Aug 22, 2023 20:19 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 3,057 | $0.50 | $1,528.50 |
DisclosureSEC source: 0001127602-23-023081 · form4.xml · nonDerivative · entry 2 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 633,744 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.460 to $0.536. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 18, 2023 Filed Aug 22, 2023 20:19 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,865 | $0.60 | $1,719.00 |
DisclosureSEC source: 0001127602-23-023081 · form4.xml · nonDerivative · entry 1 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 636,801 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.550 to $0.637. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 17, 2023 Filed Aug 18, 2023 12:01 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,733 | $0.63 | $1,721.79 |
DisclosureSEC source: 0001127602-23-022901 · form4.xml · nonDerivative · entry 2 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 639,666 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.611 to $0.631. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 12:01 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,895 | $0.65 | $1,881.75 |
DisclosureSEC source: 0001127602-23-022901 · form4.xml · nonDerivative · entry 1 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 642,399 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.631 to $0.680. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 12:59 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,629 | $0.67 | $1,761.43 |
DisclosureSEC source: 0001127602-23-022636 · form4.xml · nonDerivative · entry 2 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 645,294 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.636 to $0.712. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 12:59 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,881 | $0.63 | $1,815.03 |
DisclosureSEC source: 0001127602-23-022636 · form4.xml · nonDerivative · entry 1 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 647,923 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.621 to $0.652. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 11, 2023 Filed Aug 14, 2023 20:07 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,733 | $0.67 | $1,831.11 |
DisclosureSEC source: 0001127602-23-022479 · form4.xml · nonDerivative · entry 2 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 650,804 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.636 to $0.690. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 20:07 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,790 | $0.68 | $1,897.20 |
DisclosureSEC source: 0001127602-23-022479 · form4.xml · nonDerivative · entry 1 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 653,537 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.642 to $0.695. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 20:04 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,798 | $0.67 | $1,874.66 |
DisclosureSEC source: 0001127602-23-022281 · form4.xml · nonDerivative · entry 2 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 656,327 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.640 to $0.710. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 20:04 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,810 | $0.69 | $1,938.90 |
DisclosureSEC source: 0001127602-23-022281 · form4.xml · nonDerivative · entry 1 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 659,125 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.661 to $0.710. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 12:51 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,857 | $0.68 | $1,942.76 |
DisclosureSEC source: 0001127602-23-022219 · form4.xml · nonDerivative · entry 2 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 661,935 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.651 to $0.695. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 04, 2023 Filed Aug 9, 2023 12:51 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,550 | $0.69 | $1,759.50 |
DisclosureSEC source: 0001127602-23-022219 · form4.xml · nonDerivative · entry 1 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 664,792 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.667 to $0.726. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 03, 2023 Filed Aug 4, 2023 20:10 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,679 | $0.59 | $1,580.61 |
DisclosureSEC source: 0001127602-23-022010 · form4.xml · nonDerivative · entry 2 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 667,342 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.555 to $0.598. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 02, 2023 Filed Aug 4, 2023 20:10 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,587 | $0.52 | $1,345.24 |
DisclosureSEC source: 0001127602-23-022010 · form4.xml · nonDerivative · entry 1 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 670,021 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.480 to $0.543. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 01, 2023 Filed Aug 2, 2023 20:36 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,799 | $0.49 | $1,371.51 |
DisclosureSEC source: 0001127602-23-021846 · form4.xml · nonDerivative · entry 2 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 672,608 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.465 to $0.504. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:36 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,676 | $0.50 | $1,338.00 |
DisclosureSEC source: 0001127602-23-021846 · form4.xml · nonDerivative · entry 1 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 675,407 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.482 to $0.515. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 28, 2023 Filed Jul 31, 2023 20:05 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,647 | $0.47 | $1,244.09 |
DisclosureSEC source: 0001127602-23-021562 · form4.xml · nonDerivative · entry 2 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 678,083 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.46 to $0.49. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 27, 2023 Filed Jul 31, 2023 20:05 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,791 | $0.51 | $1,423.41 |
DisclosureSEC source: 0001127602-23-021562 · form4.xml · nonDerivative · entry 1 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 680,730 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.504 to $0.541. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 26, 2023 Filed Jul 27, 2023 20:15 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,609 | $0.52 | $1,356.68 |
DisclosureSEC source: 0000950170-23-035157 · ownership.xml · nonDerivative · entry 2 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 683,521 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.511 to $0.546. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 20:15 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,803 | $0.50 | $1,401.50 |
DisclosureSEC source: 0000950170-23-035157 · ownership.xml · nonDerivative · entry 1 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 686,130 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.491 to $0.512. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 24, 2023 Filed Jul 25, 2023 20:56 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,887 | $0.54 | $1,558.98 |
DisclosureSEC source: 0000950170-23-034474 · ownership.xml · nonDerivative · entry 2 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 688,933 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.534 to $0.561. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 21, 2023 Filed Jul 25, 2023 20:56 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,663 | $0.61 | $1,624.43 |
DisclosureSEC source: 0000950170-23-034474 · ownership.xml · nonDerivative · entry 1 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 691,820 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.604 to $0.619. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 20, 2023 Filed Jul 21, 2023 20:06 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,710 | $0.64 | $1,734.40 |
DisclosureSEC source: 0001127602-23-021132 · form4.xml · nonDerivative · entry 2 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 694,483 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.63 to $0.65. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 19, 2023 Filed Jul 21, 2023 20:06 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,646 | $0.65 | $1,719.90 |
DisclosureSEC source: 0001127602-23-021132 · form4.xml · nonDerivative · entry 1 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 697,193 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.62 to $0.65. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 18, 2023 Filed Jul 19, 2023 20:14 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,968 | $0.56 | $1,662.08 |
DisclosureSEC source: 0001127602-23-021000 · form4.xml · nonDerivative · entry 2 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 699,839 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.55 to $0.58. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 20:14 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,775 | $0.68 | $1,887.00 |
DisclosureSEC source: 0001127602-23-021000 · form4.xml · nonDerivative · entry 1 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 702,807 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.59 to $0.72. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 20:22 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 1,815 | $0.59 | $1,070.85 |
DisclosureSEC source: 0001127602-23-020818 · form4.xml · nonDerivative · entry 2 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 705,582 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.58 to $0.63. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 20:22 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,646 | $0.39 | $1,031.94 |
DisclosureSEC source: 0001127602-23-020818 · form4.xml · nonDerivative · entry 1 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 707,397 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.38 to $0.40. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 12, 2023 Filed Jul 13, 2023 20:14 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,649 | $0.39 | $1,033.11 |
DisclosureSEC source: 0001127602-23-020658 · form4.xml · nonDerivative · entry 2 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 710,043 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.38 to $0.41. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 11, 2023 Filed Jul 13, 2023 20:14 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,731 | $0.37 | $1,010.47 |
DisclosureSEC source: 0001127602-23-020658 · form4.xml · nonDerivative · entry 1 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 712,692 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.37 to $0.38. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 10, 2023 Filed Jul 11, 2023 21:24 UTC | Korro Bio, Inc. FREQ · Entity 6388 | Exercise / conversionRestricted Stock Unit · Derivative | 9,091 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-020571 · form4.xml · derivative · entry 6 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 263,636 Underlying: Common Stock · 9,091 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F5 · derivative.exercise_date: The restricted stock units will fully vest on July 4, 2023. F5 · derivative.expiration_date: The restricted stock units will fully vest on July 4, 2023. Read SEC document |
| July 10, 2023 Filed Jul 11, 2023 21:24 UTC | Korro Bio, Inc. FREQ · Entity 6388 | Exercise / conversionCommon Stock | 9,091 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-020571 · form4.xml · nonDerivative · entry 4 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 451,787 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| July 10, 2023 Filed Jul 11, 2023 21:24 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,591 | $0.38 | $984.58 |
DisclosureSEC source: 0001127602-23-020571 · form4.xml · nonDerivative · entry 3 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 442,696 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F4 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.37 to $0.38. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 10, 2023 Filed Jul 13, 2023 01:22 UTC Amendment | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 2,591 | $0.38 | $984.58 |
DisclosureSEC source: 0000950170-23-032737 · ownership.xml · nonDerivative · entry 2 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 715,423 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.37 to $0.38. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 07, 2023 Filed Jul 11, 2023 21:24 UTC | Korro Bio, Inc. FREQ · Entity 6388 | Exercise / conversionRestricted Stock Unit · Derivative | 9,091 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-020571 · form4.xml · derivative · entry 5 Lucchino David L. · CIK 0001785288 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 272,727 Underlying: Common Stock · 9,091 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F5 · derivative.exercise_date: The restricted stock units will fully vest on July 4, 2023. F5 · derivative.expiration_date: The restricted stock units will fully vest on July 4, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.